[Company Profile] Corindus Vascular Robotics
Corindus Vascular Robotics has developed a robotic system to improve percutaneous coronary intervention (PCI) placement and reduce health risks to both the patient and the physician.
Corindus Vascular Robotics has developed a robotic system to improve percutaneous coronary intervention (PCI) placement and reduce health risks to both the patient and the physician.
The company’s first product is a low-profile “Stent-On-a-Wire” system that reduces the number of steps involved in the stenting procedure.
Medical device company Stentys seeks to correct the problem of poor apposition with its self-expanding stent technology.
A new study by Abbott Laboratories found that their drug-coated stent, Xience V, is more effective in the long term than a competitor’s. According to the Wall Street Journal, the data showed that rates of major cardiovascular events plateaued at 6.4% in the second and third years after Xience was implanted.
Copyright © 2024 | WordPress Theme by MH Themes